AKT1 and Insulin resistance: Changes in S1P levels in obese and diabetic individuals can result in abnormalities in downstream insulin receptor signaling pathways, such as PI3K/Akt, thus impacting insulin sensitivity and fostering the development of insulin resistance (12).